Jornay Pm Capsule
Product Images NDC 71376-201

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Jornay Pm (NDC 71376-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ironshore Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

100mlpills V01

Image of a JORNAY PM Extended-Release capsule of 100 mg strength, marked with '100 mg' on the white lower half and 'IRONSHORE' partially visible on the dark blue upper half. The capsule is an oral dosage form with a smooth, glossy finish, displayed against a gray background with measurement scales.*

FDA Label Image

Jor00 0008 01

Chemical structure of Methylphenidate Hydrochloride, the active ingredient in JORNAY PM Extended-Release capsules. The diagram illustrates the molecular formula, including a phenyl ring, ester group, piperidine ring, and hydrochloride salt.*

FDA Label Image

Jor00 0008 02

A line graph comparing plasma methylphenidate concentration (ng/mL) over time (hours) between JORNAY PM 100 mg and Methylphenidate IR 20 mg capsules. The chart shows concentration on the y-axis and time on the x-axis, with JORNAY PM represented by triangles and Methylphenidate IR by circles, illustrating different pharmacokinetic profiles over 48 hours.*

FDA Label Image

Jor00 0008 03

A line graph comparing SKAMP Combined Scores (CS) over time between JORNAY PM Extended-Release (methylphenidate hydrochloride) and placebo. The x-axis shows time from 8am to 8pm, and the y-axis shows SKAMP CS (LS mean ± SE). The JORNAY PM group (64 participants) shows lower SKAMP CS scores throughout the day compared to the placebo group (53 participants), represented by a solid line and dashed line, respectively.*

FDA Label Image

Jor00 0008 04

Label for JORNAY PM 20 mg Extended-Release Capsules containing methylphenidate hydrochloride. The label states the capsules are for oral use with a dosage instruction to take only in the evening. It includes storage instructions and packaging information indicating 100 capsules per container, manufactured for Ironshore Pharmaceuticals Inc.*

FDA Label Image

Jor00 0008 05

Label for Jornay PM Extended-Release Capsules 40 mg containing methylphenidate hydrochloride. The label instructs to take only in the evening and states the package count as 100 capsules. It includes storage directions and manufacturer information for Ironshore Pharmaceuticals Inc.*

FDA Label Image

Jor00 0008 06

Label for Jornay PM 60 mg extended-release capsules containing methylphenidate hydrochloride. The label includes the NDC code 71376-203-03, usage instruction 'Take Only In The Evening,' and states the package contains 100 capsules. Manufacturer is Ironshore Pharmaceuticals Inc., with packaging by Patheon Puerto Rico, Inc. Storage conditions and pharmacist dispensing instructions are also provided.*

FDA Label Image

Jor00 0008 07

Label for Jornay PM Extended-Release Capsules containing 80 mg methylphenidate hydrochloride. The label instructs taking the medication only in the evening and includes a barcode. Package size is 100 capsules. The labeler is Ironshore Pharmaceuticals Inc., with packaging by Patheon Puerto Rico, Inc.*

FDA Label Image

Jor00 0008 08

Label for JORNAY PM Extended-Release Capsules containing 100 mg methylphenidate hydrochloride. The label advises to take only in the evening and includes storage instructions. The package contains 100 capsules and is labeled for prescription use only. It is manufactured for Ironshore Pharmaceuticals Inc. and packaged by Patheon Puerto Rico, Inc.*

FDA Label Image

Jornay Splimage 20mg V02

JORNAY PM Extended-Release 20 mg oral capsules, with a two-tone color design featuring a light green upper half imprinted with partial 'IRONSHOR' text and a white lower half marked with '20 mg'. Both capsule views are displayed against a measurement scale showing dimensions in millimeters.*

FDA Label Image

Jornay Splimage 40mg V02

Image of a 40 mg capsule of JORNAY PM Extended-Release (Methylphenidate Hydrochloride). The capsule is half teal and half white, with the teal half displaying partial black text likely indicating the labeler Ironshore. The white half is marked with "40 mg" in black text. The capsule size is measured against a millimeter scale.*

FDA Label Image

Jornay Splimage 60mg V02

Capsule dosage form of JORNAY PM Extended-Release, containing 60 mg Methylphenidate Hydrochloride. The capsule is blue on the top half and white on the bottom half, with "60 mg" printed on the white part and partial text visible on the blue part. Manufactured by Ironshore Pharmaceuticals Inc. The image includes a scale in millimeters for size reference.*

FDA Label Image

Jornay Splimage 80mg V02

Image of an 80 mg JORNAY PM Extended-Release capsule, containing Methylphenidate Hydrochloride. The capsule is blue on the top half with partial black text "IRONSHORE" and white on the bottom half displaying "80 mg" in black text. The capsule measures about 21 mm in length.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.